Placenta Program, Maternal-Fetal Medicine Division, Department of Obstetrics & Gynaecology, Mount Sinai Hospital, University of Toronto, 600 University Avenue, Toronto, Ontario M5G 1X5, Canada.
Placenta Program, Maternal-Fetal Medicine Division, Department of Obstetrics & Gynaecology, Mount Sinai Hospital, University of Toronto, 600 University Avenue, Toronto, Ontario M5G 1X5, Canada.
Obstet Gynecol Clin North Am. 2020 Mar;47(1):81-98. doi: 10.1016/j.ogc.2019.10.008. Epub 2019 Dec 18.
Placental dysfunction is a major contributing factor to fetal growth restriction. Placenta-mediated fetal growth restriction occurs through chronic fetal hypoxia owing to poor placental perfusion through a variety of mechanisms. Maternal vascular malperfusion is the most common placental disease contributing to fetal growth restriction; however, the role of rare placental diseases should not be overlooked. Although the features of maternal vascular malperfusion are identifiable on placental pathology, antepartum diagnostic methods are evolving. Placental imaging and uterine artery Doppler, used in conjunction with angiogenic growth factors (specifically placenta growth factor and soluble fms-like tyrosine kinase-1), play an increasingly important role.
胎盘功能障碍是胎儿生长受限的主要因素。胎盘介导的胎儿生长受限是由于各种机制导致胎盘灌注不良,引起慢性胎儿缺氧所致。胎盘疾病中,母体血管灌注异常是导致胎儿生长受限最常见的疾病,但也不应忽视罕见的胎盘疾病。虽然胎盘病理学可以识别母体血管灌注异常的特征,但产前诊断方法仍在不断发展。胎盘成像和子宫动脉多普勒检查,结合血管生成生长因子(特别是胎盘生长因子和可溶性 fms 样酪氨酸激酶-1),发挥着越来越重要的作用。